Sunday, 7 May 2017


Meet Your Target Market With members from around the world focused on learning about latest innovations in screening and treatments for heart diseases; this is your single best opportunity to reach the largest assemblage of participants from the Universities, Cardiology research centers and hospitals and conduct demonstrations of new screening instruments, distribute information about novel agents and strategies, meet with highly affiliated speakers, showing of clinical trials as well as advancements in new heart care therapies, current methods and controversies in cardiac therapy and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques for screening as well as for treatment, and the newest updates in Heart diseases and treatments are hallmarks of this conference.
A Unique Opportunity for Advertisers and Sponsors at this International event -

Tuesday, 25 April 2017

CPD credits avail @cardiac pharmacology 2017 osaka japan

Summary of Cardiac Pharmacology 2017 Conference:-
Cardiac Pharmacology 2017 is a platform for advanced technologies and provides a complete knowledge of a scientific discipline that describes the future and present trends in Cardiac research field and comprehensive update on all medical, surgical, interventional, and electrophysiological topics in cardiology. The event brings together truly innovative thinkers who are leading the way through trialing new disruptive solutions and rethinking the conventional methods used in Cardiology and Cardiovascular Pharmacology. All Organizing Committee members of the Cardiac Pharmacology 2017 look forward to meet you in Osaka, Japan.
Scope and Importance:-
Cardiac Pharmacology 2017 will be the best platform for all the scientists, cardiologists, oncologists, electro physiologists, surgeons, nurses, research scholars, students who are working in this field to exchange their knowledge related to Cardiology and Cardiac Surgery. This international event is an effort to find an alternative for invasive imaging technique against heart diseases and heart failure conditions in adults & children.
A prospective survey of patients with valvular heart disease (VHD):
·         Coronary angiography was used in 85.2% of patients before intervention.
·         The Euro Heart Survey (EHS) programme has been initiated order to provide quantitative information on cardiovascular disease.
·         To prevent the incidence of cardiovascular (CV) disease, by implementing strategies to reduce the burden of CV risk factors and incidence of CV disease, and develop appropriate models for healthy CV lifestyle.
About Venue:
Osaka is Japan’s third largest and second most important city with a population of 2.5 million. It has been the economic powerhouse of the Kansai region for many centuries. The city’s west side has the main port as well as a tourist destination with attractions such as Kyocera Dome, Universal Studios Japan, Osaka aquarium, Minami, Osaka castle, Umeda sky building and the Tempozan Harbour Village. Osaka is known for its food, both in Japan and abroad. Osaka is the second largest metropolitan area in Japan and serves a major economic hub. Historically a merchant city, Osaka has also been known as the “Nation’s Kitchen”.
Osaka is a large port city and commercial center on the Japanese island of Honshu. It's known for its modern architecture, nightlife and hearty street food. The 16th-century shogunate Osaka Castle, which has undergone several restorations, is its main historical landmark. It's surrounded by a moat and park with plum, peach and cherry-blossom trees. Sumiyoshi-taisha is among Japan’s oldest Shinto shrines.
Greatest Achievements in the Field of Cardiology:
  • Electrocardiography
  • Cardiac catheterization
  • Coronary angiography
  • Cardiovascular surgery
  • Invasive cardiology
  • The coronary care unit
  • Cardiovascular drugs
  • Preventive cardiology
  • Echocardiography
  • Cardiac Imaging Techniques
  • Pacemakers and internal defibrillators
Conference Highlights:

·         Cardiac Pharmacology
·         Heart Diseases and Failure
·         Interventional Cardiology
·         Cerebrovascular Heart Diseases
·         Cardiologists and Angiologists
·         Cardiotoxicity
·         Case Reports on Cardiology
·         Cardiovascular Nursing
·         Clinical trials in Cardiology
Target Audience:
·         Academicians
·         Directors of Cardiovascular Pharmacology department in Universities
·         Cardiologists
·         Cardiac Surgeons
·         Research laboratories
·         Professors and Associate professors
·         Assistant professors
·         Lecturers
·         Graduates and Post Graduates
·         Research scholars
·         Research and Development Department
·         Ph.D. Students
·         Scientists
Why to attend???
Meet Your Target Market With members from around the world focused on learning about latest innovations in screening and treatments for heart diseases; this is your single best opportunity to reach the largest assemblage of participants from the Universities, Cardiology research centers and hospitals and conduct demonstrations of new screening instruments, distribute information about novel agents and strategies, meet with highly affiliated speakers, showing of clinical trials as well as advancements in new heart care therapies, current methods and controversies in cardiac therapy and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques for screening as well as for treatment, and the newest updates in Heart diseases and treatments are hallmarks of this conference.
A Unique Opportunity for Advertisers and Sponsors at this International event -

Tuesday, 22 November 2016

Cardiac Pharmacology 2017

About Conference

Conference Series LLC is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. Currently we are bringing sixth Global Experts Meeting on Cardiology and Cardiovascular Pharmacology” (Cardiac Pharmacology 2017) scheduled to be held during October 20-21, 2017 at Osaka, Japan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Cardiovascular System and Medication.
Conference Series LLC organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
2017 Highlights:
  • 300+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings
Cardiac Pharmacology 2017 is comprised of 17 tracks designed to offer comprehensive sessions that addresses current issues in Cardiovascular diseases. Conference Series LLC  organizes 300+conferences, 500+workshops such as electrocardiography workshops, CVDs diagnosis workshops, cardio myopathy workshops cardiology exhibitions and 200+symposiums on ClinicalMedicinePharma and Science & Technology. 
This conference will provide a comprehensive update on all medical, surgical, interventional, and electrophysiological topics in Cardiovascular diseases and Medication. Experts with national and international reputations in various cardio sub-specialties will address the latest guidelines, practice patterns and solutions in cardiovascular medicine. Additionally, attendees will learn about recent trials being practiced that are likely to influence future practices. Interactive sessions will include discussion of current controversies in clinical practice. The areas of Cardiac Pharmacology 2017 will be covered include: heart disease, imaging, heart failure, arrhythmias, prevention and general cardiology, cardiovascular surgery, Clinical research In CVDs and interventional cardiology.
Cardiac Pharmacology events are every year across USA, Europe, Asia, Middle East, Australia and UK that support cardiology medical conferences from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. 
 According to the American Heart Association, there are approximately 6000 hospitals in the US with only 23,000 cardiologists to cover 6000 hospitals, there’s no doubt that there is a current shortage of cardiologists in the US.
With continuing advances in all areas of cardiovascular medicine, there is a need to update general and sub-specialist cardiologists on the state of the art, rapidly-evolving developments in the field. Upon completion of this course, participants should have an increased understanding of changes in practice standards and recent clinical advancements in cardiovascular medicine. An additional objective of this meeting is to provide practical knowledge and tips to improve the practice of CVDs and Medication. This conference will benefit all levels of cardiology practitioners, including doctors, professors, nurses, PhD scholars and technicians.
Cardiac Pharmacology2017 invites all interested participants to join us for this esteemed event at the exquisite destination Osaka, Japan. For more information: conference series.com
Why to attend?
6th Global Experts Meeting on Cardiology and Cardiovascular Pharmacology is among the World's leading Scientific Conference. The two days event on Cardiology and Cardiovascular Diseases   will host 60+ Scientific and technical sessions and sub-sessions on cutting edge research and latest research innovations in the field of cardiology and cardiac surgeries across the globe. This year annual Cardiac conference will comprises of 13 major sessions designed to offer comprehensive sessions that address current issues in various field of CVDs. The attendees can find-
Exclusive Sessions and Panel discussions on latest innovations in Cardiac Surgeries and Heart Failure-
Lectures by active practitioners
Keynote forums by Prominent Professors, Doctors
Open Innovation Challenges
Poster presentations by Young Researchers
Global Networking sessions with 50+ Countries
Novel techniques to benefit your research
Best platform for Global business and Networking opportunities
Meet the editors of referred journals, Society and Association members across the Globe
Excellent platform to showcase the latest products and formulations in Cardiac field
Target Audience:
  • Cardiologists
  • Cardiac Surgeons
  • University Professors
  • Various Societies and their members
  • Institutes-Medical Schools
  • Academicians: University Faculties, Research Scholars, and Scientists involved

Conference Highlights

  • Cardiac Pharmacology
  • Heart Diseases and Failure
  • Cardiovascular Pharmacotherapies, Cardiac Procedures and surgeries
  • Risk Factors for Cardiovascular Diseases
  • Interventional Cardiology
  • Nuclear Cardiology and Echocardiography
  • Cerebrovascular Heart Diseases
  • Diseases associated with Cardiovascular Diseases
  • Heart Diseases in Different Rationale
  • Cardiologists and Angiologists
  • Emerging epidemic of cardiovascular disease in developing countries
  • Cardiotoxicity
  • Cardiovascular and biological tissue regeneration and tissue engineering
  • Case Reports on Cardiology
  • Cardiovascular Nursing
  • Clinical trials in Cardiology
  • Cardiovascular Drugs Market Analysis

Special Issues

All accepted abstracts will be published in respective Journals.
Abstracts will be provided with Digital Object Identifier by Cross Ref

See more at: http://cardiac.pharmaceuticalconferences.com/